Please login to the form below
Emerging Leader
This page shows the latest Emerging Leader news and features for those working in and with pharma, biotech and healthcare.
Sanofi completes acquisition of immuno-oncology specialist Synthorx
The acquisition of Synthorx perfectly aligns with our R&D strategy, enhancing our position as an emerging leader in the area of oncology and immunology,” said Hudson (pictured left). ... leader Keytruda (pembrolizumab), which is expected to hit $14.5bn
Latest news
-
Syncona launches another cell therapy company, Treg specialist Quell
a company with the potential to be a global leader in this emerging area.”. ... leader in treating conditions of immune dysfunction utilising gene-modified cells.”.
-
Twentyeight-Seven raises another $15m for non-coding RNA drugs
This is a different approach to the emerging class of RNA therapeutics that target RNA that is directly involved in protein expression, such as antisense and RNA interference (RNAi) drugs from ... leader in capitalising on the emerging science around RNA
-
NICE recommends MSD’s diabetes drug Steglatro
Lilly and Boehringer Ingelheim’s Jardiance is emerging as the leader in the class, thanks to its strong evidence base, and Lilly increased its share of global revenues by 47% last
-
AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod
Johnson’s Stelara (targeting IL-23 and IL-12) and AbbVie’s own ageing market leader Humira. ... Confident of the drug’s best-in-class status, AbbVie also have underway a head-to-head study with the emerging market leader in the sector, Novartis’
-
Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval
Elise Wang, Principal at Deerfield Management said, “Orchard has made an impressive transition from a start-up company to an emerging leader in gene therapy for rare diseases by building a
More from news
Approximately 1 fully matching, plus 17 partially matching documents found.
Latest Intelligence
-
Making a difference with medical education
Challenging myself and our team to realise this each day at Lucid is why I come to work,”says Louise Verrall (Business Unit Director), Winner of Comm uniqué Emerging Leader in
-
Pharma deals in February 2015
Together these deals make Mylan a hormonal contraceptives leader in high-growth emerging markets.
-
Interview: Joseph Jimenez, Novartis
The vaccines &diagnostics business is a leader in 'flu, and Novartis' emerging meningitis and pneumococcal franchises will continue to drive growth, Jimenez continues. ... That is why Novartis is expanding its presence in high-growth emerging markets,
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
New hires at Abbott, Kite and Arrakis Therapeutics
Robert is the right person for Abbott's future. He is a proven Abbott leader with significant experience running Abbott's global businesses. ... chairman of its Board of Directors. She has nearly 30 years of experience in the biotech industry as a leader
-
MSD appoints Jessica Fine as UK external affairs director
She was also highly commended in the Publicis Life Brands Resolute Award for Emerging Leader in Healthcare Communications at last year's Comm uniqué Awards.
-
Douglas Williams named president and CEO of Codiak
We seek to grow Codiak into the leader in this emerging field as we strive to make new, breakthrough medicines that provide significant and lasting patient benefit.”. ... These included serving as chief scientific officer and executive vice president
-
F-star appoints GSK's Neil Brewis
He said: “F-Star is an emerging world leader in bispecfic antibody drug discovery and I am delighted to join the company at this exciting time to help maximise the potential
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications
From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference in everything she does - for her own curiosity, her
-
Lucid Group shines at the Communiqué Awards
Lucid Group’s commitment to be a leader in medical education was recognised at the Comm uniqué Awards 2016 in London last night, where the agency received three awards, including being ... It heard last night that it had won the ‘Excellence in
-
Bedrock Group
2016 Finalist: Digital Communications: PSLive, Celgene. 2016 Finalist: Emerging Leader in Healthcare Communications: Su Smith, Bedrock.
-
Lucid reach the shortlist for Communiqué 2016 in SIX categories
The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) online tool. Emerging Leader in Healthcare Communications.
-
Health Unlimited is proud sponsor of the two corporate communications categories at this year’s Communiqué Awards.
record 13th consecutive year; the company is also recognised in both Writing Excellence categories and Media Relations; Kim Lemon, Head of Liberation Unlimited, is also a finalist in the Emerging Leader
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Sinovac’s COVID-19 vaccine appears safe in older adults
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
- The five-step, rare disease-ready checklist
PMHub
Market Access Transformation
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
